Equity Overview
Price & Market Data
Price: $9.00
Daily Change: -$1.19 / 13.22%
Daily Range: $9.00 - $9.00
Market Cap: $3,177,795,072
Daily Volume: 375
Performance Metrics
1 Week: -15.73%
1 Month: -15.73%
3 Months: -36.93%
6 Months: -10.00%
1 Year: -85.39%
YTD: -36.93%
Details
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.